Document Detail


Effect of intravenous erythromycin on the colonic motility of children and young adults during colonic manometry.
MedLine Citation:
PMID:  20385286     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Erythromycin is successfully used as a gastroduodenal prokinetic agent. Given the limited available treatments for colonic dysmotility, further investigation into erythromycin's effect on colonic motility is warranted. We aimed to study the effect of erythromycin on colonic motility in pediatric patients with recalcitrant chronic constipation/encopresis and other suspected colonic motility disorders. METHODS: Patients referred for colonic manometry were eligible for enrollment. Fasting motility was recorded for 1 to 2 hours, then erythromycin lactobionate (EL), 3 mg/kg, was administered intravenously, and colonic motility was monitored for 1 to 2 hours after erythromycin. Manometry was then continued per routine. The motility index (MI) of pressure tracings at each pressure transducer was calculated for each patient for a period of 15 and 60 minutes before and after EL infusion. Change in MI was compared by Wilcoxon signed rank test. RESULTS: Twenty patients were enrolled. The most common indication was constipation with encopresis. Seventy percent of patients had normal colonic manometry, and 30% of patients demonstrated a neuropathy. Average MI for the 60-minute period before and after EL infusion were 254 +/- 74 mm Hg/h and 253 +/- 94 mm Hg/h, respectively (P = .55). Average MI for the 15-minute period before and after EL infusion were 64 +/- 23 mm Hg/15 min and 69 +/- 32 mm Hg/15 min, respectively (P = .45). CONCLUSIONS: Administration of intravenous EL resulted in no changes in colonic MI in pediatric patients referred for colonic manometry. Further studies on potential colokinetic agents are warranted in this population of patients.
Authors:
Jason Dranove; Debra Horn; S Narasimha Reddy; Joseph Croffie
Related Documents :
1880566 - Comparison of oral iodine-131-cellulose and indium-111-dtpa as tracers for colon transi...
8455106 - Screening flexible sigmoidoscopy: patient attitudes and compliance.
2767506 - Impaired bacterial flora in human excluded colon.
19625276 - Using ct colonography as a triage technique after a positive faecal occult blood test i...
8047596 - Gustatory rhinorrhea--a complication of septoplasty.
11041096 - Right atrial appendage function in patients with chronic nonvalvular atrial fibrillation.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of pediatric surgery     Volume:  45     ISSN:  1531-5037     ISO Abbreviation:  J. Pediatr. Surg.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-13     Completed Date:  2010-07-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0052631     Medline TA:  J Pediatr Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  777-83     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA. jason.dranove@carolinashealthcare.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Child, Preschool
Colonic Pseudo-Obstruction / drug therapy*
Constipation / drug therapy*
Encopresis / drug therapy*
Erythromycin / administration & dosage,  analogs & derivatives*,  pharmacology
Female
Gastrointestinal Agents / administration & dosage,  pharmacology*
Gastrointestinal Motility / drug effects*
Humans
Infusions, Intravenous
Male
Manometry
Pilot Projects
Young Adult
Chemical
Reg. No./Substance:
0/Gastrointestinal Agents; 114-07-8/Erythromycin; 3847-29-8/erythromycin lactobionate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Spinal dysraphism with anorectal malformation: lumbosacral magnetic resonance imaging evaluation of ...
Next Document:  Unexplained cervical lymphadenopathy in children: predictive factors for malignancy.